S&P 500   3,370.29 (-0.29%)
DOW   29,232.19 (-0.56%)
QQQ   234.73 (+0.04%)
AAPL   319.00 (-1.83%)
FB   217.80 (+1.69%)
MSFT   187.23 (+1.01%)
GOOGL   1,519.44 (+0.05%)
AMZN   2,155.67 (+0.97%)
CGC   21.94 (-0.86%)
NVDA   296.57 (+2.34%)
BABA   220.52 (+0.41%)
MU   57.75 (-1.28%)
GE   12.75 (-0.62%)
TSLA   858.40 (+7.30%)
AMD   56.89 (+2.86%)
ACB   1.64 (+3.80%)
F   8.06 (-0.49%)
NFLX   387.78 (+1.94%)
PRI   135.62 (-0.89%)
BAC   34.27 (-1.66%)
GILD   67.01 (-0.81%)
S&P 500   3,370.29 (-0.29%)
DOW   29,232.19 (-0.56%)
QQQ   234.73 (+0.04%)
AAPL   319.00 (-1.83%)
FB   217.80 (+1.69%)
MSFT   187.23 (+1.01%)
GOOGL   1,519.44 (+0.05%)
AMZN   2,155.67 (+0.97%)
CGC   21.94 (-0.86%)
NVDA   296.57 (+2.34%)
BABA   220.52 (+0.41%)
MU   57.75 (-1.28%)
GE   12.75 (-0.62%)
TSLA   858.40 (+7.30%)
AMD   56.89 (+2.86%)
ACB   1.64 (+3.80%)
F   8.06 (-0.49%)
NFLX   387.78 (+1.94%)
PRI   135.62 (-0.89%)
BAC   34.27 (-1.66%)
GILD   67.01 (-0.81%)
S&P 500   3,370.29 (-0.29%)
DOW   29,232.19 (-0.56%)
QQQ   234.73 (+0.04%)
AAPL   319.00 (-1.83%)
FB   217.80 (+1.69%)
MSFT   187.23 (+1.01%)
GOOGL   1,519.44 (+0.05%)
AMZN   2,155.67 (+0.97%)
CGC   21.94 (-0.86%)
NVDA   296.57 (+2.34%)
BABA   220.52 (+0.41%)
MU   57.75 (-1.28%)
GE   12.75 (-0.62%)
TSLA   858.40 (+7.30%)
AMD   56.89 (+2.86%)
ACB   1.64 (+3.80%)
F   8.06 (-0.49%)
NFLX   387.78 (+1.94%)
PRI   135.62 (-0.89%)
BAC   34.27 (-1.66%)
GILD   67.01 (-0.81%)
S&P 500   3,370.29 (-0.29%)
DOW   29,232.19 (-0.56%)
QQQ   234.73 (+0.04%)
AAPL   319.00 (-1.83%)
FB   217.80 (+1.69%)
MSFT   187.23 (+1.01%)
GOOGL   1,519.44 (+0.05%)
AMZN   2,155.67 (+0.97%)
CGC   21.94 (-0.86%)
NVDA   296.57 (+2.34%)
BABA   220.52 (+0.41%)
MU   57.75 (-1.28%)
GE   12.75 (-0.62%)
TSLA   858.40 (+7.30%)
AMD   56.89 (+2.86%)
ACB   1.64 (+3.80%)
F   8.06 (-0.49%)
NFLX   387.78 (+1.94%)
PRI   135.62 (-0.89%)
BAC   34.27 (-1.66%)
GILD   67.01 (-0.81%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 BiostageDarioHealthTitan MedicalCo-DiagnosticsObalon Therapeutics
SymbolOTCMKTS:BSTGNASDAQ:DRIONASDAQ:TMDINASDAQ:CODXNASDAQ:OBLN
Price Information
Current Price$2.45$9.18$0.39$2.92$1.98
52 Week RangeN/ABuyBuyBuyHold
Analyst Ratings
Consensus RecommendationN/ABuyBuyBuyHold
Consensus Price TargetN/A$12.00$1.50$2.00$20.63
% Upside from Price TargetN/A30.72% upside284.62% upside-31.51% downside941.67% upside
Trade Information
Market Cap$20.29 million$19.73 million$17.25 million$71.68 million$14.30 million
Beta1.570.174.62N/A-4.63
Average Volume2,99621,227290,6167,741,496268,157
Sales & Book Value
Annual RevenueN/A$7.39 millionN/A$40,000.00$9.10 million
Price / SalesN/A2.78N/A1,576.141.68
CashflowN/AN/AN/AN/AN/A
Price / CashN/AN/AN/AN/AN/A
Book Value$0.35 per share$5.32 per share$0.19 per share($0.08) per share$5.57 per share
Price / BookN/A1.73N/A-36.500.36
Profitability
Net Income$-7,530,000.00$-17,800,000.00$-22,640,000.00$-6,270,000.00$-37,380,000.00
EPSN/AN/A($1.36)N/A($19.60)
Trailing P/E RatioN/AN/AN/A0.00N/A
Forward P/E RatioN/AN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net MarginsN/A-248.57%N/A-5,486.08%-607.48%
Return on Equity (ROE)-557.99%-325.50%N/A-202.74%-228.96%
Return on Assets (ROA)-354.60%-159.70%-165.51%-152.56%-103.25%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.02%0.12%N/AN/A0.03%
Current Ratio1.67%1.70%0.19%10.01%5.72%
Quick Ratio1.67%1.35%0.19%9.96%5.20%
Ownership Information
Institutional Ownership Percentage0.18%N/A5.41%5.30%19.81%
Insider Ownership Percentage6.70%19.70%N/A9.00%14.30%
Miscellaneous
Employees1569922100
Shares Outstanding8.28 million2.24 million40.41 million21.59 million7.73 million
Next Earnings Date3/26/2020 (Estimated)3/23/2020 (Estimated)2/19/2020 (Estimated)2/19/2020 (Estimated)2/27/2020 (Confirmed)
OptionableNot OptionableNot OptionableNot OptionableNot OptionableOptionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel